Total records found: 208
Hide HeadlineShow Headline
Sort
Release Time Stock Code Stock Short Name Document
Release Time: 16/10/2026 08:00 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT-(1) UPDATE ON PRODUCT REVENUE FOR THE FIRST THREE QUARTERS OF 2026 AND (2) NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVES THE NEW INDICATION MARKETING APPLICATION FOR STAPOKIBART FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN ADOLESCENTS (101KB)
Release Time: 05/10/2026 16:33 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026 (65KB)
Release Time: 22/09/2026 17:03 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
2026 INTERIM REPORT (4MB)
Release Time: 06/09/2026 18:31 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (79KB)
Release Time: 06/09/2026 18:29 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]
RESIGNATION OF NON-EXECUTIVE DIRECTOR (71KB)
Release Time: 02/09/2026 21:03 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ENTERED INTO A LICENSING AGREEMENT IN RELATION TO THE MARKETING REGISTRATION AND COMMERCIALIZATION OF STAPOKIBART INJECTION IN 18 COUNTRIES AND REGIONS INCLUDING SOUTHEAST ASIA AND CENTRAL ASIA (97KB)
Release Time: 02/09/2026 16:39 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2026 (65KB)
Release Time: 19/08/2026 21:31 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION - PROPOSED ISSUE OF RMB SHARES AND LISTING ON THE SCI-TECH BOARD OF THE SHANGHAI STOCK EXCHANGE (76KB)
Release Time: 19/08/2026 21:23 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Interim Results]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026 (578KB)
Release Time: 10/08/2026 08:00 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF CM512 (TSLP x IL-13 BISPECIFIC ANTIBODY) INJECTION FOR PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS ACHIEVED ALL STUDY ENDPOINTS (79KB)
Release Time: 07/08/2026 16:31 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (71KB)
Release Time: 03/08/2026 16:44 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026 (65KB)
Release Time: 28/07/2026 12:00 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - CMG901 (AZD0901) CLARITY-Gastric01 GLOBAL PHASE III CLINICAL TRIAL ACHIEVES POSITIVE TOPLINE RESULTS (81KB)
Release Time: 23/07/2026 12:00 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - CM512 INCLUDED IN THE BREAKTHROUGH THERAPY DESIGNATION LIST BY THE CENTER FOR DRUG EVALUATION OF THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION (449KB)
Release Time: 15/07/2026 22:37 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT - (1) UPDATE ON PRODUCT REVENUE FOR THE FIRST HALF OF 2026 AND (2) POSITIVE PROFIT ALERT (101KB)
Release Time: 03/07/2026 18:07 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026 (65KB)
Release Time: 26/06/2026 21:26 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Results of AGM]
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 26, 2026 (81KB)
Release Time: 05/06/2026 12:04 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - UPDATE ON DISPOSAL OF EQUITY INTEREST IN OURO MEDICINES (78KB)
Release Time: 02/06/2026 16:43 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026 (65KB)
Release Time: 06/05/2026 16:50 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 (65KB)
Release Time: 29/04/2026 16:46 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Proxy Forms
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING (97KB)
Release Time: 29/04/2026 16:45 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]
NOTICE OF ANNUAL GENERAL MEETING (105KB)
Release Time: 29/04/2026 16:45 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory...
More
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory Statement for Repurchase of Shares / Other]
]
(1) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF ANNUAL GENERAL MEETING (280KB)
Release Time: 29/04/2026 16:44 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Financial Statements/ESG Information - [Annual Report / Environmental, Social and Governance Information/Report]
2025 ANNUAL REPORT (9MB)
Release Time: 15/04/2026 21:58 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Discloseable Transaction]
SUPPLEMENTAL ANNOUNCEMENT TO DISCLOSEABLE TRANSACTION DISPOSAL OF EQUITY INTEREST IN OURO MEDICINES (77KB)
Release Time: 01/04/2026 16:38 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 (65KB)
Release Time: 26/03/2026 20:54 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 (882KB)
Release Time: 24/03/2026 06:29 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Discloseable Transaction]
DISCLOSEABLE TRANSACTION DISPOSAL OF EQUITY INTEREST IN OURO MEDICINES (91KB)
Release Time: 16/03/2026 16:55 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (71KB)
Release Time: 10/03/2026 16:59 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - UPDATE ON COLLABORATION WITH ASTRAZENECA ON CORE PRODUCT CMG901 (AZD0901) (78KB)
Release Time: 02/03/2026 16:40 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 (65KB)
Release Time: 02/02/2026 16:31 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 (65KB)
Release Time: 05/01/2026 16:48 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 (63KB)
Release Time: 01/12/2025 18:05 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 (62KB)
Release Time: 03/11/2025 17:02 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 (62KB)
Release Time: 02/10/2025 16:57 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 (62KB)
Release Time: 25/09/2025 19:00 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
2025 INTERIM REPORT (2MB)
Release Time: 02/09/2025 16:41 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 (62KB)
Release Time: 26/08/2025 16:36 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Interim Results / Change in Directors or of Important Executive Functions or Responsibilities...
More
Announcements and Notices - [Interim Results / Change in Directors or of Important Executive Functions or Responsibilities / Change in Company Secretary]
]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025; AND RESIGNATION OF CHIEF FINANCIAL OFFICER AND JOINT COMPANY SECRETARY (649KB)
Release Time: 14/08/2025 16:39 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (71KB)
Release Time: 04/08/2025 16:47 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 (63KB)
Release Time: 02/07/2025 16:33 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 (64KB)
Release Time: 26/06/2025 19:35 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Results of AGM]
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 26, 2025 (81KB)
Release Time: 19/06/2025 17:53 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (84KB)
Release Time: 19/06/2025 17:48 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER THE GENERAL MANDATE (155KB)
Release Time: 11/06/2025 08:06 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
(1) PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER THE GENERAL MANDATE AND (2) SALE OF SHARES BY THE TOP-UP VENDOR (198KB)
Release Time: 03/06/2025 16:38 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 (63KB)
Release Time: 06/05/2025 17:19 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 (62KB)
Release Time: 28/04/2025 21:22 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Proxy Forms
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING (98KB)
Release Time: 28/04/2025 21:18 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]
NOTICE OF ANNUAL GENERAL MEETING (105KB)
Release Time: 28/04/2025 21:14 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory...
More
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory Statement for Repurchase of Shares / Other]
]
(1) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF ANNUAL GENERAL MEETING (286KB)
Release Time: 28/04/2025 21:11 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Financial Statements/ESG Information - [Annual Report / Environmental, Social and Governance Information/Report]
2024 ANNUAL REPORT (6MB)
Release Time: 03/04/2025 16:54 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 (62KB)
Release Time: 24/03/2025 21:20 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Terms of Reference of the Nomination Committee]
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE (86KB)
Release Time: 24/03/2025 21:12 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (79KB)
Release Time: 24/03/2025 21:05 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024; AND CHANGE OF COMPOSITION OF THE NOMINATION COMMITTEE (505KB)
Release Time: 12/03/2025 16:33 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (71KB)
Release Time: 03/03/2025 16:43 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 (62KB)
Release Time: 07/02/2025 16:30 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT NMPA APPROVED THE SNDA OF STAPOKIBART FOR THE TREATMENT OF SEASONAL ALLERGIC RHINITIS (119KB)
Release Time: 05/02/2025 16:40 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 (63KB)
Release Time: 20/01/2025 18:00 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT LICENSE AGREEMENT WITH PROLIUM FOR THE DEVELOPMENT AND COMMERCIALIZATION OF CM355 (ICP-B02) (88KB)
Release Time: 10/01/2025 08:00 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE LICENSE AGREEMENT FOR CM313 (78KB)
Release Time: 03/01/2025 16:37 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 (63KB)
Release Time: 23/12/2024 16:30 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT NMPA APPROVED THE SNDA OF STAPOKIBART FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (95KB)
Release Time: 16/12/2024 21:00 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Change in Registered Address or Office, Registered Place of Business in HK or Agent for...
More
Announcements and Notices - [Change in Registered Address or Office, Registered Place of Business in HK or Agent for Service of Process in HK]
]
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG (71KB)
Release Time: 09/12/2024 16:30 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT THE LATEST DATA FROM THE PHASE I/II CLINICAL STUDY OF CM336 AT THE 66TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING BY WAY OF A POSTER (77KB)
Release Time: 03/12/2024 16:34 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 (62KB)
Release Time: 17/11/2024 18:04 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT FOR CM336 (85KB)
Release Time: 01/11/2024 16:36 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 (62KB)
Release Time: 02/10/2024 16:34 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 (62KB)
Release Time: 23/09/2024 21:01 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
2024 INTERIM REPORT (2MB)
Release Time: 12/09/2024 18:15 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT STAPOKIBART WAS GRANTED MARKETING APPROVAL FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN ADULTS (96KB)
Release Time: 02/09/2024 16:54 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 (62KB)
Release Time: 27/08/2024 18:23 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Interim Results]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 (457KB)
Release Time: 15/08/2024 16:35 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (71KB)
Release Time: 02/08/2024 16:35 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 (63KB)
Release Time: 09/07/2024 08:15 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION - EXCLUSIVE LICENSE AGREEMENT FOR CM512 AND CM536 (67KB)
Release Time: 04/07/2024 17:01 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 (63KB)
Release Time: 25/06/2024 20:14 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Constitutional Documents
SIXTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION (188KB)
Release Time: 25/06/2024 20:06 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Results of AGM]
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 25, 2024 (71KB)
Release Time: 20/06/2024 08:15 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT RESULTS FROM AN EXPLORATORY CLINICAL STUDY OF CM313 IN ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA WERE RECENTLY PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE (68KB)
Release Time: 07/06/2024 08:00 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF STAPOKIBART INJECTION FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS ACCEPTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION (89KB)
Release Time: 05/06/2024 16:43 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 (61KB)
Release Time: 03/06/2024 08:15 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT LONG-TERM EFFICACY AND SAFETY DATA FROM A PHASE III CLINICAL TRIAL OF STAPOKIBART INJECTION AT THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY (EAACI) CONGRESS 2024 (85KB)
Release Time: 02/06/2024 18:06 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT THE LATEST RESULTS FROM A PHASE I CLINICAL STUDY OF CMG901 (AZD0901) AT THE ASCO ANNUAL MEETING 2024 BY WAY OF ORAL PRESENTATION (68KB)
Release Time: 23/05/2024 16:30 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT STAPOKIBART INJECTION INCLUDED IN THE PRIORITY REVIEW AND APPROVAL PROCEDURES FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (82KB)
Release Time: 06/05/2024 16:34 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 (61KB)
Release Time: 30/04/2024 08:15 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF STAPOKIBART INJECTION FOR THE TREATMENT OF SEASONAL ALLERGIC RHINITIS ACCEPTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION (89KB)
Release Time: 28/04/2024 18:04 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF STAPOKIBART INJECTION FOR THE TREATMENT OF SEASONAL ALLERGIC RHINITIS ACHIEVED PRIMARY ENDPOINTS (83KB)
Release Time: 24/04/2024 16:37 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Circulars - [Other]
Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications (700KB)
Release Time: 24/04/2024 16:35 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Circulars - [Other]
Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications (750KB)
Release Time: 24/04/2024 16:34 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Proxy Forms
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING (109KB)
Release Time: 24/04/2024 16:33 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]
NOTICE OF ANNUAL GENERAL MEETING (114KB)
Release Time: 24/04/2024 16:32 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory...
More
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory Statement for Repurchase of Shares / Amendment of Constitutional Documents / Other]
]
(1) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (4) RE-APPOINTMENT OF AUDITOR; AND (5) NOTICE OF ANNUAL GENERAL MEETING (198KB)
Release Time: 24/04/2024 16:30 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Financial Statements/ESG Information - [Annual Report / Environmental, Social and Governance Information/Report]
2023 ANNUAL REPORT (4MB)
Release Time: 12/04/2024 08:15 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT UPDATE ON THE LICENSE AGREEMENT WITH ASTRAZENECA ON CMG901 (AZD0901) (71KB)
Release Time: 08/04/2024 16:52 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 (61KB)
Release Time: 26/03/2024 21:39 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period / Amendment of...
More
Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period / Amendment of Constitutional Documents]
]
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY (773KB)
Release Time: 14/03/2024 16:31 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (60KB)
Release Time: 06/03/2024 16:38 Stock Code: 02162 Stock Short Name: KEYMED BIO-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 (61KB)
Showing 100 of 208 records
Showing 100 of 208 records
Disclaimer

Information contained in the materials available under the web page containing the hyperlink to this disclaimer is posted on this website for the purpose of providing information to the public in Hong Kong. It is not intended as investment advice and must not be relied on as such. It is the sole responsibility of any person who is located outside of Hong Kong to check and comply with all applicable laws and regulations before accessing and using the materials and information.

Please note that the web page contains materials and information provided to HKEX electronically (including information provided in electronic format) by listed issuers, new listing applicants and relevant parties and there is no agency, employee or partner relationship between HKEX and such parties. HKEX does not assume responsibility for screening, editing or monitoring such materials and the information contained in the materials. The information contained in the materials is not verified by HKEX.

HKEX and/or its subsidiaries take no responsibility for the materials and information available under the web page, make no representation as to their accuracy, reliability, completeness or ownership and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information. Some materials may contain hyperlinks to external websites or web pages for which HKEX and/or its subsidiaries are not responsible. (Please see HKEX's "Hyperlink Policy").

Nothing herein shall constitute or be considered to be a limitation upon or a waiver of the privileges and immunities of HKEX and its subsidiaries, which are specifically reserved.

Copyright exists in the information and materials available under the web page and may belong to HKEX, to the author or to any other party depending on the circumstances of publications. Reproduction, distribution, use and/or linking without consent from the relevant parties is not permitted.

If you believe or are aware that any information contained in the materials is inaccurate, erroneous, unlawful, obscene, defamatory or infringes any intellectual property rights of a third party, please contact HKEX e-Submission by email at: ESSHotline@hkex.com.hk.